drugset / Trial / NCT05215158

Intravenous Versus Peribulbar Dexmedetomidine for Strabismus Surgery in Adults

NCT05215158 ↗

Completed 46 enrolled Aswan University Hospital
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Using various adjuvants has become a trend in regional anesthesia practice to improve the quality of anesthesia and prolong postoperative analgesia. Dexmedetomidine, an alpha-2 agonist has been proposed as a safe and effective adjunct capable of extending the duration of the single-shot block

Timeline

Start
2022-01-28
Primary completion
2023-07-01
Completion
2023-09-15

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dexmedetomidine Other / unclassified 50 ug Intravenous

Indications